Intravenous and Subcutaneous Administration of RG6234, a Novel GPRC5DxCD3 T-Cell Engaging Bispecific Antibody, Is Highly Active in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Biomarker Results from a Phase I Study
Resource Type
Abstract
Authors
Dekhtiarenko, Iryna ; Lelios, Iva ; Attig, Jan ; Sleiman, Nassim ; Lazzaro, Domenico ; Schindler, Emilie ; Eckmann, Jan ; Umana, Pablo ; Jacob, Wolfgang ; Schneider, Meike ; Carlo-Stella, Carmelo ; Mazza, Rita ; Manier, Salomon ; Facon, Thierry ; Yoon, Sung-Soo ; Koh, Youngil ; Harrison, Simon J ; Er, Jeremy ; Pinto, Antonio ; Volzone, Francesco ; Perrone, Giulia ; Corradini, Paolo ; Cazaubiel, Titouan ; Hulin, Cyrille ; Touzeau, Cyrille ; Moreau, Philippe ; Ocio, Enrique M. ; Montes Gaisan, Carmen Maria ; Popat, Rakesh ; Leong, Sarah ; Offner, Fritz ; Rodriguez Otero, Paula ; Alfonso-Pierola, Ana ; Hutchings, Martin ; Riley, Caroline Hasselbalch ; Bröske, Ann-Marie E
Source
In Blood 15 November 2022 140 Supplement 1:10137-10139
Subject
Language
ISSN
0006-4971